Investigation of active peptides from natural products that induce ER-stress-mediated apoptosis in cancer as potential therapeutics for kidney cancer, common in some genetic diseases: An in silico approach
kidney cancer treatment by peptides
Abstract
Background: Endoplasmic reticulum (ER) stress initiates an unfolded protein response (UPR) to re-establish ER homeostasis as an adaptive pathway in cancer. However, persistent ER stress triggers the apoptotic pathway usually observed in kidney cancer (KC). The term KC actually refers to a number of distinct cancers. Kidney cancer is generally observed in a number of genetic diseases. Treatment options for KC have changed greatly over the years. The most commonly used tyrosine kinase inhibitors, TKI, show conflicting results regarding their beneficial effects on patients, as demonstrated in different KC patient cohort studies, indicating that the underlying molecular mechanisms involved in KC are more complex and likely need combined therapies able to modulate the activity of endoplasmic reticulum. Methods: The purpose of this research was to generate peptides from natural products in sillico that might be used as kidney cancer potential modulators. For this aim, several methods were used: Target prediction, protein hydrolysis, and protein-peptide molecular docking have all been used as techniques. Results: The network of critical KC genes is composed of C3AR1, CSNK2A2, ACE, DPP4, CAPN1, FPR2, HLA-A, and MMP2, together with predicted kinases such as RPS6KA5, MAPK14, CSNK2A1, PRKCD, CDK1, and HIPK2, in addition to transcription factors such as IRF8, TCF3, ERG, CREB1, EZH2, SPI1, IRF1, and SUZ12. The identified molecular targets of the isolated peptides are: HLA class I histocompatibility antigen A-3, lipoxin A4, dipeptidyl peptidase IV, angiotensinconverting enzyme, cyclooxygenase-2, C3a anaphylatoxin chemotactic receptor, melanocortin receptor 4, neurotensin receptor 1, mu opioid receptor, delta opioid receptor, and calpain 1. Conclusion: Overall, the results showed that GVSK, PGP, WQR, YGGF, and IF peptides are promising candidates for further study. Future work would be needed to test the therapeutic properties of these hydrolysate peptides using in vitro and in vivo approaches.
Keywords:
Genetic diseases,, Kidney cancer,, peptide treatment,, molecular docking.DOI
https://doi.org/10.22270/jddt.v13i11.6307References
Garlatti M, Barouki R. Le stress du réticulum endoplasmique : adaptation et toxicité. médecine/sciences 2002;18:585–94. https://doi.org/10.1051/medsci/2002185585 .
Correia de Sousa M, Delangre E, Türkal M, Foti M, Gjorgjieva M. Endoplasmic Reticulum Stress in Renal Cell Carcinoma. Int J Mol Sci 2023;24:4914. https://doi.org/10.3390/ijms24054914 .
Kim C, Kim B. Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review. Nutrients 2018;10:1021. https://doi.org/10.3390/nu10081021.
Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primer 2017;3:17009. https://doi.org/10.1038/nrdp.2017.9.
Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, et al. Epidemiology of Renal Cell Carcinoma. World J Oncol 2020;11:79–87. https://doi.org/10.14740/wjon1279.
Linehan WM, Ricketts CJ. The metabolic basis of kidney cancer. Semin Cancer Biol 2013;23:46–55. https://doi.org/10.1016/j.semcancer.2012.06.002.
Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317–20. https://doi.org/10.1126/science.8493574.
Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, Schmidt L, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 2002;11:393–400.
Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002;2:157–64. https://doi.org/10.1016/s1535-6108(02)00104-6.
Gustafson S, Zbuk KM, Scacheri C, Eng C. Cowden syndrome. Semin Oncol 2007;34:428–34. https://doi.org/10.1053/j.seminoncol.2007.07.009.
Afshar Ebrahimi F, Foroozanfard F, Aghadavod E, Bahmani F, Asemi Z. The Effects of Magnesium and Zinc Co-Supplementation on Biomarkers of Inflammation and Oxidative Stress, and Gene Expression Related to Inflammation in Polycystic Ovary Syndrome: a Randomized Controlled Clinical Trial. Biol Trace Elem Res 2018;184:300–7. https://doi.org/10.1007/s12011-017-1198-5.
Kurrikoff K, Aphkhazava D, Langel Ü. The future of peptides in cancer treatment. Curr Opin Pharmacol 2019;47:27–32. https://doi.org/10.1016/j.coph.2019.01.008.
Hung J-Y, Hsu Y-L, Ni W-C, Tsai Y-M, Yang C-J, Kuo P-L, et al. Oxidative and endoplasmic reticulum stress signaling are involved in dehydrocostuslactone-mediated apoptosis in human non-small cell lung cancer cells. Lung Cancer Amst Neth 2010;68:355–65. https://doi.org/10.1016/j.lungcan.2009.07.017.
Yang KM, Kim BM, Park J-B. ω-Hydroxyundec-9-enoic acid induces apoptosis through ROS-mediated endoplasmic reticulum stress in non-small cell lung cancer cells. Biochem Biophys Res Commun 2014;448:267–73. https://doi.org/10.1016/j.bbrc.2014.04.111.
Wu S-H, Hang L-W, Yang J-S, Chen H-Y, Lin H-Y, Chiang J-H, et al. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways. Anticancer Res 2010;30:2125–33.
Hsia T-C, Yu C-C, Hsu S-C, Tang N-Y, Lu H-F, Huang Y-P, et al. Cantharidin induces apoptosis of H460 human lung cancer cells through mitochondria-dependent pathways. Int J Oncol 2014;45:245–54. https://doi.org/10.3892/ijo.2014.2428.
Xu W-S, Dang Y-Y, Guo J-J, Wu G-S, Lu J-J, Chen X-P, et al. Furanodiene induces endoplasmic reticulum stress and presents antiproliferative activities in lung cancer cells. Evid-Based Complement Altern Med ECAM 2012;2012:426521. https://doi.org/10.1155/2012/426521.
Zhao X, Liu X, Su L. Parthenolide induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung cancer cells. J Exp Clin Cancer Res CR 2014;33:3. https://doi.org/10.1186/1756-9966-33-3.
Seong Y-A, Shin P-G, Yoon J-S, Yadunandam AK, Kim G-D. Induction of the endoplasmic reticulum stress and autophagy in human lung carcinoma A549 cells by anacardic acid. Cell Biochem Biophys 2014;68:369–77. https://doi.org/10.1007/s12013-013-9717-2.
Chakraborty S, Rahman T. The difficulties in cancer treatment. Ecancermedicalscience 2012;6:ed16. https://doi.org/10.3332/ecancer.2012.ed16.
Guida F, Tan VY, Corbin LJ, Smith-Byrne K, Alcala K, Langenberg C, et al. The blood metabolome of incident kidney cancer: A case–control study nested within the MetKid consortium. PLoS Med 2021;18:e1003786. https://doi.org/10.1371/journal.pmed.1003786.
Zugazagoitia J, Guedes C, Ponce S, Ferrer I, Molina-Pinelo S, Paz-Ares L. Current Challenges in Cancer Treatment. Clin Ther 2016;38:1551–66. https://doi.org/10.1016/j.clinthera.2016.03.026.
Zhang F, Qi L, Feng Q, Zhang B, Li X, Liu C, et al. HIPK2 phosphorylates HDAC3 for NF-κB acetylation to ameliorate colitis-associated colorectal carcinoma and sepsis. Proc Natl Acad Sci U S A 2021;118:e2021798118. https://doi.org/10.1073/pnas.2021798118.
Jin X, Qing S, Li Q, Zhuang H, Shen L, Li J, et al. Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP–HIPK2 axis. Nucleic Acids Res 2021;49:6788–803. https://doi.org/10.1093/nar/gkab489.
NCBI. HIPK2 homeodomain interacting protein kinase 2 [Homo sapiens (human)] - Gene - NCBI 2011. https://www.ncbi.nlm.nih.gov/gene/28996 (accessed August 4, 2023).
Hu Z, Li L, Lan W, Wei X, Wen X, Wu P, et al. Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human Osteosarcoma. Cancer Res Treat Off J Korean Cancer Assoc 2022;54:277–93. https://doi.org/10.4143/crt.2021.320.
Chae SW, Sohn JH, Kim D-H, Choi YJ, Park YL, Kim K, et al. Overexpressions of Cyclin B1, cdc2, p16 and p53 in Human Breast Cancer: The Clinicopathologic Correlations and Prognostic Implications. Yonsei Med J 2011;52:445–53. https://doi.org/10.3349/ymj.2011.52.3.445.
Sofi S, Mehraj U, Qayoom H, Aisha S, Almilaibary A, Alkhanani M, et al. Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors. Med Oncol Northwood Lond Engl 2022;39:133. https://doi.org/10.1007/s12032-022-01748-2.
Ren L, Yang Y, Li W, Zheng X, Liu J, Li S, et al. CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis. J Transl Med 2022;20:444. https://doi.org/10.1186/s12967-022-03641-y.
Liu J, Yu X, Yu H, Liu B, Zhang Z, Kong C, et al. Knockdown of MAPK14 inhibits the proliferation and migration of clear cell renal cell carcinoma by downregulating the expression of CDC25B. Cancer Med 2019;9:1183–95. https://doi.org/10.1002/cam4.2795.
Taylan E, Zayou F, Murali R, Karlan BY, Pandol SJ, Edderkaoui M, et al. Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model. Gynecol Oncol 2020;159:277–84. https://doi.org/10.1016/j.ygyno.2020.07.005.
Liu Z, Li Y, Li X, Zhao J, Wu S, Wu H, et al. Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway. Mol Ther Oncolytics 2020;17:21. https://doi.org/10.1016/j.omto.2020.03.006.
Bernardini A, Mukherjee P, Scheer E, Kamenova I, Antonova S, Sanchez PKM, et al. Hierarchical TAF1-dependent co-translational assembly of the basal transcription factor TFIID. bioRxiv 2023:2023.04.05.535704. https://doi.org/10.1101/2023.04.05.535704.
Rivera C, Lee H-G, Lappala A, Wang D, Noches V, Olivares-Costa M, et al. Unveiling RCOR1 as a rheostat at transcriptionally permissive chromatin. Nat Commun 2022;13:1550. https://doi.org/10.1038/s41467-022-29261-0.
Czerwińska P, Mazurek S, Wiznerowicz M. The complexity of TRIM28 contribution to cancer. J Biomed Sci 2017;24:63. https://doi.org/10.1186/s12929-017-0374-4.
Yu X, Li Z, Bai R, Tang F. Transcriptional factor 3 binds to sirtuin 1 to activate the Wnt/β-catenin signaling in cervical cancer. Bioengineered 2022;13:12516–31. https://doi.org/10.1080/21655979.2022.2076481.
Zoma M, Curti L, Shinde D, Albino D, Mitra A, Sgrignani J, et al. EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer. Nat Commun 2021;12:4147. https://doi.org/10.1038/s41467-021-24380-6.
Xu X, Wang X, Chen Q, Zheng A, Li D, Meng Z, et al. Sp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer. J Transl Med 2023;21:307. https://doi.org/10.1186/s12967-023-04141-3.
Young M-J, Chen Y-C, Wang S-A, Chang H-P, Yang W-B, Lee C-C, et al. Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression. J Biomed Sci 2022;29:3. https://doi.org/10.1186/s12929-022-00787-1.
Müller I, Strozyk E, Schindler S, Beissert S, Oo HZ, Sauter T, et al. Cancer cells employ nuclear caspase-8 to overcome the p53-dependent G2/M checkpoint through cleavage of USP28. Mol Cell 2020;77:970-984.e7. https://doi.org/10.1016/j.molcel.2019.12.023.
Tummers B, Green DR. Caspase-8; regulating life and death. Immunol Rev 2017;277:76–89. https://doi.org/10.1111/imr.12541.
Zong L, Chen K, Jiang Z, Chen X, Sun L, Ma J, et al. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer. J Exp Clin Cancer Res CR 2017;36:181. https://doi.org/10.1186/s13046-017-0655-5.
Nazarian A, Lawlor K, Yi SS, Philip J, Ghosh M, Yaneva M, et al. Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer. Mol Cell Proteomics MCP 2014;13:3082. https://doi.org/10.1074/mcp.M114.038836.
Knoll S, Zimmer S, Hinney A, Scherag A, Neubauer A, Hebebrand J. Val103Ile polymorphism of the melanocortin-4 receptor gene (MC4R) in cancer cachexia. BMC Cancer 2008;8:85. https://doi.org/10.1186/1471-2407-8-85.
Shu C, Zha H, Long H, Wang X, Yang F, Gao J, et al. C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts. J Exp Clin Cancer Res CR 2020;39:11. https://doi.org/10.1186/s13046-019-1515-2.
Viet CT, Dang D, Aouizerat BE, Miaskowski C, Ye Y, Viet DT, et al. OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients. J Pain Off J Am Pain Soc 2017;18:1046–59. https://doi.org/10.1016/j.jpain.2017.04.001.
Momeni HR. Role of Calpain in Apoptosis. Cell J Yakhteh 2011;13:65–72.
Published
Abstract Display: 234 
PDF Downloads: 189 PDF Downloads: 92 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.